Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 013500/0067 | |
| Pages: | 8 |
| | Recorded: | 11/14/2002 | | |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
09888182
|
Filing Dt:
|
06/22/2001
|
|
Publication #:
|
|
Pub Dt:
|
08/28/2003
| | | | |
|
Title:
|
Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of Erk-5
|
|
|
Assignee
|
|
|
|
|
| 130 WAVERLY STREET |
| CAMBRIDGE, MASSACHUSETTS 02139-4242 |
|
|
Correspondence name and address
|
| |
VERTEX PHARMACEUTICALS INCORPORATED
|
| |
ANDREA L.C. ROBIDOUX
|
| |
130 WAVERLY STREET
|
| |
CAMBRIDGE, MA 02138-4242
|
Search Results as of:
05/01/2024 08:44 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
